Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11023618 | 0.98 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL50400 | 0.80 | ALDH1A1 (0.43) | ALDH1A1TSHR | |
| SCHEMBL1119824 | 0.74 | LMNA (0.46) | ALDH1A1TSHR | |
| SCHEMBL3728027 | 0.74 | GABRR1 (0.31) | — | |
| Acrylamide SCHEMBL29170832 | 0.73 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL466386 | 0.72 | GRIK1 (0.31) | — | |
| SCHEMBL13192615 | 0.72 | CYP1A2 (0.30) | — | |
| SCHEMBL7568558 | 0.72 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL27959803 | 0.72 | — | — | |
| SCHEMBL9279118 | 0.71 | GRIK1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2438902-B1 | CLEANSING METHOD | KAO CORP (JP) | 2020-02-26 | — | — | EP | claimed |
| EP-1786446-B1 | Hydroalcoholic extract of Uncaria tomentosa for the treatment of herpes virus infection | HERBARIUM LABORATÓRIO BOTÁNICO LTDA (BR) | 2015-09-30 | — | — | EP | claimed |
| EP-3151816-A1 | NIACINAMIDE-BASED DERMATOLOGICAL COMPOSITION | Espa SA-Experts in Science&Product Achievements (FR) | 2017-04-12 | — | — | EP | disclosed |
| WO-2015185867-A1 | NIACINAMIDE-BASED DERMATOLOGICAL COMPOSITION | ESPA SA-EXPERTS IN SCIENCE & PRODUCT ACHIEVEMENTS (FR) | 2015-12-10 | — | — | WO | disclosed |
| US-20090209642-A1 | Hydroxy Acid Complexes for Antiaging and Skin Renovation | BIODERM RESEARCH (US) | 2009-08-20 | — | — | US | disclosed |
| US-7547454-B2 | Hydroxy acid complexes for antiaging and skin renovation | GUPTA SHYAM K | 2009-06-16 | — | — | US | disclosed |
| US-20070166255-A1 | Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition | GUPTA SHYAM K | 2007-07-19 | — | — | US | disclosed |
| US-20070092461-A1 | Novel Hydroxy Acid Complexes for Antiaging and Skin Renovation | BIODERM RESEARCH (US) | 2007-04-26 | — | — | US | disclosed |
| US-20060147508-A1 | Concurrent Enhancement of Skin Penetration of Organic Base Active Agents and Organic Hydroxy Acid Active Agents as Their Ion-Pair Complexes | BIODERM RESEARCH (US) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209642-A1 | Hydroxy Acid Complexes for Antiaging and Skin Renovation | CUTA, SLC30A6, SLC30A7 | ALDH1A1 1013/4885TSHR 2369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.